You are here:
Name SMC ID No Manufacturer Status Sub. Type
 
5 aminolaevulinic acid (Ameluz) 1260/17 Biofrontera Bioscience GmbH Not Recommended Full submission
5-aminolaevulinic acid (Ameluz) 811/12 Biofrontera Bioscience GmbH Accepted Full submission
5-aminolaevulinic acid (Ameluz) 1260/17 Biofrontera Bioscience GmbH Accepted Resubmission
adalimumab (Humira) 218/05 Abbott Laboratories Superseded Full submission
adalimumab (Humira) 1143/16 AbbVie Ltd Accepted Full submission
adalimumab (Humira) 468/08 Abbott Laboratories Restricted Full submission
adalimumab (Humira) 1243/17 AbbVie Ltd Accepted Abbreviated Submission
adapalene 0.1% of Benzoyl Peroxide (Epiduo Gel) 682/11 Galderma (UK) Ltd Not Recommended Full submission
adapalene 0.1%/benzoyl peroxide 2.5% gel (Epiduo®) 682/11 Galderma (UK) Ltd Restricted Resubmission
alitretinion (Toctino) 538/09 Basilea Pharmaceuticals Ltd Accepted Full submission
azelaic acid (Finacea 15% gel) 359/07 Valeant Pharmaceuticals Ltd Accepted Full submission
betamethasone valerate 2.25mg medicated plaster (Betesil) 622/10 Genus Pharmaceuticals Not Recommended Full submission
brimonidine (Mirvaso) 1016/14 Galderma (UK) Ltd Restricted Full submission
brodalumab (Kyntheum) 1283/17 LEO Pharmaceuticals Not Recommended Full submission
calcipotriol + betamethasone (Enstilar) 1182/16 LEO Pharmaceuticals Accepted Abbreviated Submission
calcipotriol 50 mcg/g / betamethasone 05 mg/g (Xamiol Gel®) 559/09 LEO Pharmaceuticals Accepted Full submission
Calcipotriol and betamethasone ointment (Dovobet®) 09/02 LEO Pharmaceuticals Restricted Resubmission
Calcipotriol and bethamethasone ointment (Dovobet®) 09/02 LEO Pharmaceuticals Not Recommended Full submission
Calcitriol 3ug/g for psoriasis (Silkis Ointment®) 43/03 Galderma (UK) Ltd Accepted Full submission
camellia sinensis (green tea leaf) (Catephen) 1133/16 Kora Healthcare Restricted Full submission
clindamycin 1% / tretinoin 0.025% gel (Treclin®) 1010/14 Meda Pharmaceuticals Ltd Accepted Abbreviated Submission
Clindamycin 1% and benzoyl peroxide 5% gel (Duac® once daily gel) 92/04 Stiefel Laboratories Restricted Full submission
clobetasol propionate (Etrivex Shampoo) 434/07 Galderma (UK) Ltd Accepted Resubmission
clobetasol propionate 0.05% cutaneous foam (Clarelux) 280/06 3M Healthcare Ltd Accepted Abbreviated Submission
clobetasol propionate 0.05% shampoo (Etrivex) 434/07 Galderma (UK) Ltd Not Recommended Abbreviated Submission
Efalizumab (Raptiva®) 146/04 Serono Ltd Marketing Authorisation Withdrawn Full submission
Eflornithine 11.5% cream (Vaniqa®) 159/05 Shire Pharmaceuticals Restricted Resubmission
Eflornithine 11.5% cream (Vaniqa®) 159/05 Shire Pharmaceuticals Not Recommended Full submission
etanercept (Enbrel) 842/13 Pfizer Ltd Restricted Abbreviated Submission
etanercept (Enbrel) 570/09 Wyeth Pharmaceuticals Superseded Abbreviated Submission
fluocinolone acetonide (Iluvien) 864/13 Alimera Sciences Not Recommended Full submission
fluorouracil + salicylic acid (Actikerall) 728/11 Almirall Ltd Accepted Full submission
golimumab (Simponi) 674/11 MSD Not Recommended Full submission
imiquimod (Zyclara) 934/13 Meda Pharmaceuticals Ltd Not Recommended Non submission
imiquimod 5% cream (Aldara) 385/07 Meda Pharmaceuticals Ltd Not Recommended Full submission
imiquimod 5% cream (Aldara) 385/07 Meda Pharmaceuticals Ltd Restricted Resubmission
Imiquimod 5% cream (Aldara®) 167/05 3M Healthcare Ltd Restricted Full submission
infliximab 100mg powder for intravenous infusion (Remicade) 318/06 Schering-Plough Ltd Restricted Full submission
ingenol mebutate gel (Picato) 851/13 LEO Pharmaceuticals Accepted Full submission
ivermectin (Soolantra) 1104/15 Galderma (UK) Ltd Restricted Full submission
ixekizumab (Taltz) 1223/17 Eli Lilly and Company Ltd Restricted Full submission
Methyl aminolevulinate (Metvix cream®) 50/03 Galderma (UK) Ltd Accepted Resubmission
Methyl aminolevulinate (Metvix cream®) 50/03 Galderma (UK) Ltd Not Recommended Full submission
Methyl aminolevulinate (Metvix cream®) 51/03 Galderma (UK) Ltd Restricted Resubmission
Methyl aminolevulinate (Metvix cream®) 51/03 Galderma (UK) Ltd Not Recommended Full submission
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended IRP
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended Resubmission
retapamulin (Altargo) 472/08 GlaxoSmithKline UK Ltd Not Recommended Non submission
tacrolimus (Protopic) 608/10 Astellas Pharma Ltd Accepted Full submission
tacrolimus (Protopic) 0.1% ointment 609/10 Astellas Pharma Ltd Accepted Full submission
Tacrolimus ointment (Protopic®) 12/02 Fujisawa Restricted Full submission
ustekinumab (Stelara) 572/09 Janssen-Cilag Ltd Restricted Full submission
ustekinumab (Stelara) 944/14 Janssen-Cilag Ltd Accepted Full submission
ustekinumab (Stelara) 1115/15 Janssen-Cilag Ltd Superseded Abbreviated Submission

Back